Thyroglobulin (Tg) and calcitonin are commonly used as tumor biomarkers for several years regarding the postoperative follow-up evaluation of ThyC, according to the guidelines of the American Thyroid Association (ATA) [8]. The gene discussed is TG; the disease is neoplasm.